Treatment of neurodegenerative disease with sodium chlorite
AssigneesNeuvivo, Inc., The Regents of the University of California
InventorsVernon A. Norviel, Michael S. McGrath
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
Claims14
A method of treating a dementia in a subject in need thereof, the method comprising:
- a) determining that the subject has a plasma level of C-reactive protein that is at least 1125 ng/ml;
- and
- b) based on the determining that the subject has the plasma level of C-reactive protein that is at least 1125 ng/mL, administering to the subject an amount of sodium chlorite that is therapeutically-effective for the dementia.
Dependencies are inferred from the claim text.